Supratentorial pediatric cortical ependymomas: a comprehensive retrospective study
- PMID: 32607870
- DOI: 10.1007/s10143-020-01336-w
Supratentorial pediatric cortical ependymomas: a comprehensive retrospective study
Abstract
Pediatric cortical ependymomas (CEs) are rare; the clinical features and optimal treatment remain ill-defined. We aimed to clarify the clinical characteristics and outcome of pediatric CEs based on institutional series and literature review. Thirteen children with CEs from our department were included in the present study. Furthermore, a search of English language peer-reviewed articles yielded 43 patients with CEs. The clinical data, treatment, and outcome were retrospectively reviewed and statistically analyzed. Our institutional series consisted of nine males and four females. The literature review yielded 56 pediatric CE cases (including ours) for further analysis. Of these 56 cases, frontal lobe (n = 19, 41.3%) was the most common location and most of the tumors were located in the right hemisphere (n = 27, 58.7%). Seizures (n = 23, 41.1%) were the most frequent preoperative symptoms. Thirty patients (n = 30, 53.6%) were WHO grade II. Five continuous patients in our series screened for C11orf95-RELA fusion and all the patients (100%) were RELA fusion positive. Fourteen (26.4%) patients experienced tumor recurrence and 4 (7.5%) patients died during the follow-up. Multivariate survival analysis depicted extent of surgery resection was the only prognostic factor for PFS and patient with gross total resection (P = 0.037, HR 3.682, 95% CI 1.082-13.79) had longer PFS. Furthermore, Log-rank testing for Kaplan-Meier survival analysis showed the extent of surgery resection (P = 0.007) was the only prognostic factor for OS. Pediatric CEs are rare, commonly seen in frontal lobe and right hemisphere. Seizures are the most common symptoms. They may have higher rate of RELA fusions, but favorable outcome. A low incidence of anaplastic histology has been depicted. Gross total resection is significantly associated with longer PFS and OS. Careful follow-up is necessary because the tumors may progress.
Keywords: Cortical ependymomas; Outcome; Pediatric; Treatment.
Similar articles
-
The Survival and Prognostic Factors of Supratentorial Cortical Ependymomas: A Retrospective Cohort Study and Literature-Based Analysis.Front Oncol. 2020 Aug 21;10:1585. doi: 10.3389/fonc.2020.01585. eCollection 2020. Front Oncol. 2020. PMID: 32974195 Free PMC article.
-
Supratentorial Cortical Ependymomas: A Retrospective Series of 13 Cases at a Single Center.World Neurosurg. 2018 Apr;112:e772-e777. doi: 10.1016/j.wneu.2018.01.153. Epub 2018 Jan 31. World Neurosurg. 2018. PMID: 29408575
-
Supratentorial extraventricular ependymomas: A retrospective study focused on long-term outcomes and prognostic factors.Clin Neurol Neurosurg. 2018 Feb;165:1-6. doi: 10.1016/j.clineuro.2017.12.013. Epub 2017 Dec 13. Clin Neurol Neurosurg. 2018. PMID: 29253745
-
Supratentorial cortical ependymoma: case series and review of the literature.Neuropathology. 2014 Jun;34(3):243-52. doi: 10.1111/neup.12087. Epub 2013 Dec 20. Neuropathology. 2014. PMID: 24354554 Review.
-
Supratentorial hemispheric ependymomas: an analysis of 109 adults for survival and prognostic factors.J Neurosurg. 2016 Aug;125(2):410-8. doi: 10.3171/2015.7.JNS151187. Epub 2016 Jan 8. J Neurosurg. 2016. PMID: 26745489 Review.
Cited by
-
Supratentorial cortical ependymoma: A systematic literature review and case illustration.Rare Tumors. 2022 Jul 8;14:20363613221112432. doi: 10.1177/20363613221112432. eCollection 2022. Rare Tumors. 2022. PMID: 35836750 Free PMC article. Review.
-
Gas Chromatographic-Ion Mobility Spectrometry Combined with Chemometrics to Study the Changes in Characteristic Odor Components of Galli gigerii Endothelium Corneum in Different Processing Methods.J Anal Methods Chem. 2023 Aug 7;2023:2259280. doi: 10.1155/2023/2259280. eCollection 2023. J Anal Methods Chem. 2023. PMID: 37583472 Free PMC article.
-
Nuclear condensates of YAP fusion proteins alter transcription to drive ependymoma tumourigenesis.Nat Cell Biol. 2023 Feb;25(2):323-336. doi: 10.1038/s41556-022-01069-6. Epub 2023 Feb 2. Nat Cell Biol. 2023. PMID: 36732631
References
-
- Amirian ES, Armstrong TS, Aldape KD, Gilbert MR, Scheurer ME Predictors of survival among pediatric and adult ependymoma cases: a study using Surveillance, Epidemiology, and End Results data from 1973 to 2007
-
- Nakazato Y (2008) The 4th edition of WHO classification of tumours of the central nervous system published in 2007. No shinkei geka Neurological surgery 36:473–491 - PubMed
-
- Archer TC, Pomeroy SL (2015) Defining the molecular landscape of ependymomas. Cancer Cell 27:613–615. https://doi.org/10.1016/j.ccell.2015.04.015 - DOI - PubMed
-
- Guyotat J, Signorelli F, Desme S, Frappaz D, Madarassy G, Montange MF, Jouvet A, Bret P (2002) Intracranial ependymomas in adult patients: analyses of prognostic factors. J Neuro-Oncol 60:255–268. https://doi.org/10.1023/a:1021136029072 - DOI
-
- Hollon T, Nguyen V, Smith BW, Lewis S, Junck L, Orringer DA (2016) Supratentorial hemispheric ependymomas: an analysis of 109 adults for survival and prognostic factors. J Neurosurg 125:410–418. https://doi.org/10.3171/2015.7.JNS151187 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources